NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes

Lise Tarnow

Status: Completed

Conditions: Diabetic Neuropathy

Study type: Observational

Funder types: Other

Identifiers

NCT01707979

NIR

Details and patient eligibility

About

The aim of the study is to examine the suitability to detect diabetic neuropathy using NIR and impedance.

Full description

The aim of the study is to examine how suitable a hand-held measuring probe (DDD-probe) using NIR (near infrared light) as well as impedance (conductivity), is to detect early signs of diabetic neuropathy.

The DDD-probe is put directly on the skin and is measuring by the use of light and impedance.

Enrollment: 30 patients

Sex: Male

Ages: 35 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• men with type 1 diabetes (WHO criteria)
• age 35-50 years
• duration of diabetes > 10 years

Exclusion criteria

• P-creatinine> 120 micromol/l
• other acute or chronic disease, or type of treatment that makes the patient unsuitable to participate, valuated by the investigator
• non intact skin on the measuring spots
• the patient is unable to understand the informed consent

Trial design

30 participants in 3 patient groups

Diabetic neuropathy

Description:

Male participants, type1 diabetic with diabetic neuropathy

Diabetes without neuropathy

Description:

Male participants, type1 diabetic without diabetic neuropathy

Non diabetic control

Description:

Male participants, control group non diabetic